Stanford University
Showing 12,101-12,150 of 13,057 Results
-
Yiyu Wang
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioDr. Yiyu Wang is a T32 postdoctoral researcher at the Department of Anesthesiology, Stanford School of Medicine. Her research combines computational models and neuroimaging techniques to characterize the neural architecture underlying complex human experiences in emotion and pain. Her current work focuses on leveraging deep learning, foundation models, and explainable AI to improve neuroimaging-based markers as well as multi-modal markers of chronic pain.
-
Yunyun Wang
Postdoctoral Scholar, Cardiovascular Medicine
BioYunyun is a postdoctoral scholar in Cardiovascular Medicine at Stanford. She received her PhD in Genetics from Zhejiang University in China (2025), where she studied the metabolic-epigenetic mechanisms of cardiovascular disease such as atherosclerosis and angiogenesis. In 2026, she joined the Quertermous Lab, where her research focuses on uncovering the mechanisms underlying atherosclerosis using Perturb-seq technology.
-
Dr. Zhiyong Wang
Visiting Scholar, Genetics
BioDr. Wang is the acting director of the Department of Plant Biology, Carnegie Institution for Science, and a professor by courtesy of the Department of Biology, Stanford University. He is currently an associate editor of Molecular Cellular Proteomics, and editorial board member of Molecular Plant. He is a Fellow of the American Association for the Advancement of Science (AAAS) and recipient of the Humboldt Research Prize.
Dr. Wang obtained his Ph.D. in 1998 from UCLA, where he cloned the plant circadian clock gene CCA1. He did his postdoctoral research at the Salk Institute, where he studied the brassinosteroid signaling mechanism mediated by the BRI1 receptor kinase. Since joining Carnegie in 2001, his research has illustrated the receptor kinase signaling pathway that links the BRI1 receptor kinase to the BZR1 transcription factor and brassinosteroid-responsive genes in the Arabidopsis genome. He further demonstrated how the steroid signaling pathway integrates at the molecular level with other hormonal pathways, light signaling pathways, nutrient-sensing pathways, immunity pathways, and the circadian clock, to coordinately regulate plant growth and development. His lab uses combinations of genomic and proteomic approaches to understand how cellular signals are transduced and integrated through posttranslational modifications (e.g. phosphorylation and O-Glycosylation) and protein-protein interactions. His studies are elucidating the molecular mechanisms that control plant growth and mediate responses to environmental changes. -
Ziwei Wang
Postdoctoral Scholar, Radiation Therapy
Current Research and Scholarly InterestsMy current work focuses on establishing preclinical platforms to rapidly validate the functional impact of genetic alterations in tumors using both cell and genetically engineered mouse models. We hope this system can accelerate the discovery and translation of novel cancer therapies to patients.
-
Zongyi Wang
Postdoctoral Scholar, Psychiatry
Current Research and Scholarly InterestsSleep disruptions in neurodegenerative disorders
-
Irene Wapnir, MD
Professor of Surgery (General Surgery)
Current Research and Scholarly InterestsClinical trials in operative procedures such as Nipple-sparing mastectomy, arm lymphatic mapping, skin perfusion and Treatments for Breast Cancer, especially local recurrence. Dr. Wapnir is institutional Principal Investigator and Chair for National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. Laboratory and translational research includes exploring the activity of breast iodide transporter in breast cancer brain metastasis.
-
(Alex) Alexandra Ward
Clinical Research Coordinator Associate, Pediatrics - Endocrinology
Bio(Alex) Alexandra Ward is a Clinical Research Coordinator in the Department of Pediatric Endocrinology at Stanford University School of Medicine. She works on a broad portfolio of clinical research studies focused on improving health outcomes for children and adolescents through patient-centered, technology-enabled, and equity-focused approaches. In her role, she coordinates industry-sponsored and investigator-initiated studies, oversees participant recruitment and study operations, manages regulatory compliance, and contributes to qualitative and quantitative data analysis, scientific writing, and dissemination of research findings.
Alexandra earned her Bachelor of Arts in Sociology with a focus on Pre-Medical Studies from the University of California, Berkeley. Her academic and research interests center on epidemiology, population health, and the social and structural factors that influence health across the lifespan. She is particularly interested in health equity, social determinants of health, implementation science, digital health technologies, aging, and the use of artificial intelligence to improve healthcare delivery and reduce disparities among underserved populations.
Her research experience spans pediatric endocrinology, chronic disease management, epidemiology, mixed-methods research, patient-reported outcomes, and community-engaged research. She has contributed to multiple peer-reviewed publications and scientific presentations and has collaborated on studies examining diabetes technology, healthcare access, quality of life, and interventions designed to improve health outcomes for diverse patient populations.
Alexandra plans to pursue a PhD in Epidemiology, where she hopes to develop innovative, data-driven approaches to address complex public health challenges and advance equitable healthcare through interdisciplinary research. -
Katherine T. Ward, MD
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Ward is the Chief of the Geriatrics Section in the Department of Medicine, Division of Primary Care and Population Health at Stanford University School of Medicine, and a Clinical Professor of Medicine. In this leadership role, she supervises program leaders across outpatient, inpatient, and skilled nursing facility settings, bringing them together to provide longitudinal, coordinated care to older adults across the healthcare continuum.
Dr. Ward is a fellowship-trained geriatrician with Stanford in Palo Alto, California, and is board certified in geriatric medicine, hospice and palliative medicine, and internal medicine. Her clinical practice spans all care settings—outpatient clinics, hospitals, and skilled nursing facilities—with a focus on managing the critical transitions between them. She specializes in comprehensive care for older adults, including dementia care, palliative care, geriatric assessment, and best practices in nursing home care. Dr. Ward draws on her extensive experience to teach and implement evidence based models that support care for older adults. Dr. Ward's research interests include early detection of dementia in vulnerable populations, dementia care support programs, and geriatric assessment in diverse populations.
She has published her research in peer-reviewed journals including the Journal of the American Geriatrics Society; The American Journal of Geriatric Pharmacotherapy; The Journal of Nutrition, Health & Aging; and the Journal of Palliative Medicine. She has served as an ad hoc reviewer for several journals, including Geriatrics, and has presented posters at annual meetings of the American Geriatrics Society and the Society of General Internal Medicine.
Dr. Ward is a member of the American College of Physicians and the American Geriatrics Society. -
Victoria Ward
Clinical Professor, Pediatrics
Current Research and Scholarly InterestsGlobal child health, Health AI in LMICs, preterm birth, human trafficking
https://digitalmedic.stanford.edu/
https://htdatalab.stanford.edu/ -
Chisondi S. Warioba, PhD
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioChisondi S. Warioba, PhD, is a Postdoctoral Scholar in the Division of Pain Medicine at the Stanford University School of Medicine, working in the Department of Anesthesiology, Perioperative and Pain Medicine with Dr. Sean Mackey and Dr. Kenneth Weber. His research develops machine learning and deep learning approaches for high-dimensional medical data, with an emphasis on cross-species translational neuroscience, resting-state fMRI, and multimodal MRI analysis (NODDI, DKI, and advanced diffusion techniques) to identify brain biomarkers of chronic pain.
He earned his PhD in Medical Physics from the University of Chicago, where his dissertation focused on cross-species mapping of functional connectivity alterations and therapeutic responses in hyperacute ischemic stroke. He completed a triple-major bachelor's degree in Chemistry, Physics, and Biology at Westmont College.
Dr. Warioba is a National Science Foundation Graduate Research Fellow and was awarded an Academic Visitor position at the University of Oxford's Department of Clinical Neurosciences. He received the Carl B. Allendoerfer Award from the Mathematical Association of America for expository excellence. He is committed to mentorship and community engagement, including STEM outreach for underrepresented students and neuroscience public education. -
Roger Warnke
Ronald F. Dorfman, M.B.B.ch., FRCPath, Professor in Hematopathology, Emeritus
Current Research and Scholarly InterestsAs an Emeritus Professor, I no longer have a research laboratory and am now fully retired.
-
Jenli Dawn Waters, MD
Clinical Assistant Professor, Neurosurgery
BioDr. Waters is a board-certified, fellowship-trained neurosurgeon with the Neurosurgery Program at Stanford Health Care. She is also a clinical assistant professor of neurosurgery in the Department of Neurosurgery at Stanford University School of Medicine.
Dr. Waters specializes in treating a wide range of spinal conditions. These treatments include surgery to relieve numbness or pain related to pressure on the spinal cord and procedures to repair or stabilize the spinal column (spine fusion). Her areas of expertise also include diagnosis and treatment of traumatic brain injury and brain and spinal cancers.
Dr. Waters’ research experience includes helping to develop effective strategies for diagnosing
and treating patients with different neurological cancers, including glioblastomas. As a subspecialty medical expert for spine and neurosurgery, she successfully advocated for insurance coverage of state-of-the-art, minimally invasive approaches to treating epilepsy and brain tumors.
Dr. Waters has published her work in peer-reviewed journals, including the Journal of Neurosurgery and the Journal of Neuro-Oncology. She has also authored and co-authored chapters in numerous books describing neurosurgical techniques and the diagnosis and treatment of various neurological conditions, including brain and spinal cord tumors.
Dr. Waters is a member of the Congress of Neurological Surgeons. -
Ronald D. Watkins
Senior Research Engineer, Rad/Radiological Sciences Laboratory
Current Role at StanfordMy current position is Senior Research Associate in the Radiological Sciences Laboratory and the Molecular Imaging Laboratory in the Department of Radiology at Stanford School of Medicine. I provide hardware, systems, and general technical support for a large group of Faculty members and many students and post docs in the development of advanced medical imaging, metabolic imaging and image-guided interventions. My training background is primarily in RF and electrical engineering. I have spent more than 25 years in the commercial diagnostic imaging industry. Most of the projects I am currently working on involve instrumentation for metabolic imaging using magnetic deuterium imaging. I am also involved in the development of Hybrid systems that combine Positron Emission Tomography and Magnetic Resonance imaging. Other projects I am involved in use focused ultrasound for neuro-stimulation or drug delivery via blood brain barrier. I also provide RF coil design and support for small animal imaging and various research studies. I have ongoing collaborations with many other medical research institutes and Universities around the world. I currently have 45 issued US patents, and 100 pear reviewed publications.
-
Erin Watson, PsyD, ABPP
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioErin Watson, PsyD, ABPP, is a board-certified clinical health psychologist and Clinical Associate Professor in the Division of Gastroenterology & Hepatology at Stanford University School of Medicine. She specializes in helping people understand and manage the psychological, behavioral, and lifestyle factors that can affect their physical health. Her clinical interests include coping with chronic illness, managing stress and health-related anxiety, making sustainable health behavior changes, and using evidence-based mind-body and behavioral approaches to improve symptoms, functioning, and quality of life.
Dr. Watson has specialized in health psychology and behavioral medicine throughout her education, training, and career. She completed her doctoral training with an emphasis in Primary Care Psychology and Behavioral Medicine, followed by advanced training in health psychology and integrated medical care and a postdoctoral fellowship focused on infectious and liver diseases. Before joining Stanford, she spent more than a decade at the San Francisco VA and UCSF providing behavioral health care within medical settings, including primary care, chronic pain, liver and infectious disease, bariatric medicine, and outpatient health psychology.
At Stanford, Dr. Watson is part of GI & Liver Behavioral Medicine, where she works with adults living with digestive and liver conditions. Her work in psychogastroenterology addresses the important connections between the brain, behavior, and digestive system. She also has a particular interest in advancing psycho-hepatology, which brings health psychology and behavioral medicine into liver care. Her goal is to help patients develop practical skills for coping with illness, managing symptoms and stress, changing health behaviors, and living well alongside chronic medical conditions.
Dr. Watson is a dedicated clinician-educator with more than a decade of experience teaching and supervising psychology trainees and educating healthcare professionals across disciplines. Her current academic work includes research examining behavioral approaches to chronic pain and opioid use through a National Institutes of Health-funded study, as well as a recently funded Patient-Centered Outcomes Research Institute (PCORI) study evaluating behavioral interventions for people living with rare liver diseases. Across her clinical care, research, teaching, and program development, she works to advance the integration of psychological and behavioral science into medical care and improve the health and quality of life of people living with chronic disease. -
Kathleen Watson
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKathleen Watson, Ph.D., currently serves as an instructor at Stanford University School of Medicine, specializing in Epidemiology and Clinical Research. She co-founded Microclinic International in 2007, where she served as Chief Operating Officer until 2012, focusing on socially-based health interventions for underserved communities.
Dr. Watson's research encompasses various aspects of mental health and metabolism. She investigates the connection between insulin resistance and depression, using computational psychiatry to uncover insights into the interplay of metabolic factors in mental well-being. Additionally, her exploration of cognitive aging examines how metabolic alterations might impact cognitive decline and related disorders. Furthermore, her research in proteomics aims to identify potential biomarkers for severe major depressive disorder. Dr. Watson has recently become a part of the Stanford Autism Center for Excellence Data Core, where she works under the guidance of Dr. Booil Jo. -
Robert Waymouth
Robert Eckles Swain Professor of Chemistry and Professor, by courtesy, of Chemical Engineering
BioRobert Eckles Swain Professor in Chemistry Robert Waymouth investigates new catalytic strategies to create useful new molecules, including bioactive polymers, synthetic fuels, and sustainable plastics. In one such breakthrough, Professor Waymouth and Professor Wender developed a new class of gene delivery agents.
Born in 1960 in Warner Robins, Georgia, Robert Waymouth studied chemistry and mathematics at Washington and Lee University in Lexington, Virginia (B.S. and B.A., respectively, both summa cum laude, 1982). He developed an interest in synthetic and mechanistic organometallic chemistry during his doctoral studies in chemistry at the California Institute of Technology under Professor R.H. Grubbs (Ph.D., 1987). His postdoctoral research with Professor Piero Pino at the Institut fur Polymere, ETH Zurich, Switzerland, focused on catalytic hydrogenation with chiral metallocene catalysts. He joined the Stanford University faculty as assistant professor in 1988, becoming full professor in 1997 and in 2000 the Robert Eckles Swain Professor of Chemistry.
Today, the Waymouth Group applies mechanistic principles to develop new concepts in catalysis, with particular focus on the development of organometallic and organic catalysts for the synthesis of complex macromolecular architectures. In organometallic catalysis, the group devised a highly selective alcohol oxidation catalyst that selectively oxidizes unprotected polyols and carbohydrates to alpha-hyroxyketones. In collaboration with Dr. James Hedrick of IBM, we have developed a platform of highly active organic catalysts and continuous flow reactors that provide access to polymer architectures that are difficult to access by conventional approaches.
The Waymouth group has devised selective organocatalytic strategies for the synthesis of functional degradable polymers and oligomers that function as "molecular transporters" to deliver genes, drugs and probes into cells and live animals. These advances led to the joint discovery with the Wender group of a general, safe, and remarkably effective concept for RNA delivery based on a new class of synthetic cationic materials, Charge-Altering Releasable Transporters (CARTs). This technology has been shown to be effective for mRNA based cancer vaccines.
